Aqua Medical’s through-the-endoscope, 30-minute outpatient treatment represents an intervention to enhance control for individuals with type 2 diabetes.

Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.

BIOCAPTIVA is an award-winning biotechnology company based in Edinburgh, dedicated to revolutionising liquid biopsy and nucleic acid (NA) extraction. Harnessing our proprietary msX™ polymer technology, we are addressing critical challenges in the liquid biopsy market, empowering breakthroughs in genetic disease detection, diagnosis, monitoring, and treatment.Our advanced extraction method ensures unparalleled cell-free NA yield and quality, driving progress in precision medicine and multi-omics research.𝗪𝗵𝗮𝘁 𝗦𝗲𝘁𝘀 𝗨𝘀 𝗔𝗽𝗮𝗿𝘁: 𝗢𝘂𝗿 𝗣𝗮𝘁𝗲𝗻𝘁𝗲𝗱 𝗡𝗔-𝗕𝗶𝗻𝗱𝗶𝗻𝗴 𝗣𝗼𝗹𝘆𝗺𝗲𝗿𝘀Our innovative, biocompatible NA-binding polymers offer unmatched benefits:𝗙𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆: Customisable coatings for diverse substrate formats, including bead-based systems and automated workflows.𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗶𝘁𝘆: Effortlessly captures cell-free NAs from simple and complex solutions without the need for additional reagents or preservatives.𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗶𝘁𝘆: Prioritises rare cell-free NA fragments by minimising high molecular weight NA capture, enabling comprehensive sample profiling.𝗦𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆: Safeguards bound NAs at room temperature for up to 90 days.𝗟𝗶𝗺𝗶𝘁𝗹𝗲𝘀𝘀 𝗖𝗮𝗽𝗮𝗰𝗶𝘁𝘆: Processes sample volumes ranging from millilitres to litres, offering exceptional scalability.At BIOCAPTIVA, we are driving transformative advancements in biotechnology to unlock new horizons in genetic disease management and multi-omics research. Together, we’re shaping the future of precision medicine.

CAPS Medical is a medical device company focused on the development and commercialization of cancer treatment using Cold Atmospheric Plasma.

338501 are Authorised Representatives of Synchron Australian Financial Services Licensee No. 243313 Synchronised Business Services Pty Ltd –ABN 33 007 207 650 – AFS Licence No. 243313 – Life Insurance Broker PO Box 438, North Melbourne, Vic, 3051

We deliver actionable business intelligence solutions by providing information and insights to help your business achieve success. To know more, connect today!

Aqua Medical’s through-the-endoscope, 30-minute outpatient treatment represents an intervention to enhance control for individuals with type 2 diabetes.

Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.

BIOCAPTIVA is an award-winning biotechnology company based in Edinburgh, dedicated to revolutionising liquid biopsy and nucleic acid (NA) extraction. Harnessing our proprietary msX™ polymer technology, we are addressing critical challenges in the liquid biopsy market, empowering breakthroughs in genetic disease detection, diagnosis, monitoring, and treatment.Our advanced extraction method ensures unparalleled cell-free NA yield and quality, driving progress in precision medicine and multi-omics research.𝗪𝗵𝗮𝘁 𝗦𝗲𝘁𝘀 𝗨𝘀 𝗔𝗽𝗮𝗿𝘁: 𝗢𝘂𝗿 𝗣𝗮𝘁𝗲𝗻𝘁𝗲𝗱 𝗡𝗔-𝗕𝗶𝗻𝗱𝗶𝗻𝗴 𝗣𝗼𝗹𝘆𝗺𝗲𝗿𝘀Our innovative, biocompatible NA-binding polymers offer unmatched benefits:𝗙𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆: Customisable coatings for diverse substrate formats, including bead-based systems and automated workflows.𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗶𝘁𝘆: Effortlessly captures cell-free NAs from simple and complex solutions without the need for additional reagents or preservatives.𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗶𝘁𝘆: Prioritises rare cell-free NA fragments by minimising high molecular weight NA capture, enabling comprehensive sample profiling.𝗦𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆: Safeguards bound NAs at room temperature for up to 90 days.𝗟𝗶𝗺𝗶𝘁𝗹𝗲𝘀𝘀 𝗖𝗮𝗽𝗮𝗰𝗶𝘁𝘆: Processes sample volumes ranging from millilitres to litres, offering exceptional scalability.At BIOCAPTIVA, we are driving transformative advancements in biotechnology to unlock new horizons in genetic disease management and multi-omics research. Together, we’re shaping the future of precision medicine.

CAPS Medical is a medical device company focused on the development and commercialization of cancer treatment using Cold Atmospheric Plasma.

338501 are Authorised Representatives of Synchron Australian Financial Services Licensee No. 243313 Synchronised Business Services Pty Ltd –ABN 33 007 207 650 – AFS Licence No. 243313 – Life Insurance Broker PO Box 438, North Melbourne, Vic, 3051

We deliver actionable business intelligence solutions by providing information and insights to help your business achieve success. To know more, connect today!

Aqua Medical’s through-the-endoscope, 30-minute outpatient treatment represents an intervention to enhance control for individuals with type 2 diabetes.

Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.

BIOCAPTIVA is an award-winning biotechnology company based in Edinburgh, dedicated to revolutionising liquid biopsy and nucleic acid (NA) extraction. Harnessing our proprietary msX™ polymer technology, we are addressing critical challenges in the liquid biopsy market, empowering breakthroughs in genetic disease detection, diagnosis, monitoring, and treatment.Our advanced extraction method ensures unparalleled cell-free NA yield and quality, driving progress in precision medicine and multi-omics research.𝗪𝗵𝗮𝘁 𝗦𝗲𝘁𝘀 𝗨𝘀 𝗔𝗽𝗮𝗿𝘁: 𝗢𝘂𝗿 𝗣𝗮𝘁𝗲𝗻𝘁𝗲𝗱 𝗡𝗔-𝗕𝗶𝗻𝗱𝗶𝗻𝗴 𝗣𝗼𝗹𝘆𝗺𝗲𝗿𝘀Our innovative, biocompatible NA-binding polymers offer unmatched benefits:𝗙𝗹𝗲𝘅𝗶𝗯𝗶𝗹𝗶𝘁𝘆: Customisable coatings for diverse substrate formats, including bead-based systems and automated workflows.𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗶𝘁𝘆: Effortlessly captures cell-free NAs from simple and complex solutions without the need for additional reagents or preservatives.𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗶𝘁𝘆: Prioritises rare cell-free NA fragments by minimising high molecular weight NA capture, enabling comprehensive sample profiling.𝗦𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆: Safeguards bound NAs at room temperature for up to 90 days.𝗟𝗶𝗺𝗶𝘁𝗹𝗲𝘀𝘀 𝗖𝗮𝗽𝗮𝗰𝗶𝘁𝘆: Processes sample volumes ranging from millilitres to litres, offering exceptional scalability.At BIOCAPTIVA, we are driving transformative advancements in biotechnology to unlock new horizons in genetic disease management and multi-omics research. Together, we’re shaping the future of precision medicine.

CAPS Medical is a medical device company focused on the development and commercialization of cancer treatment using Cold Atmospheric Plasma.

338501 are Authorised Representatives of Synchron Australian Financial Services Licensee No. 243313 Synchronised Business Services Pty Ltd –ABN 33 007 207 650 – AFS Licence No. 243313 – Life Insurance Broker PO Box 438, North Melbourne, Vic, 3051

We deliver actionable business intelligence solutions by providing information and insights to help your business achieve success. To know more, connect today!